Abstract: Implementations provide for automated container migration in a Platform-as-a-Service (PaaS) system. A method of the disclosure includes receiving, by a processing device executing a control server of a multi-tenant Platform-as-a-Service (PaaS) system, identification of a distressed node of the multi-tenant PaaS system and a resource under contention at the distressed node, providing, by the control server, identification of the resource under contention to the distressed node, receiving, by the control server, identification of a candidate container executing on the distressed node, wherein the candidate container contributes to the resource under contention on the distressed node and is launched from an instance of an application image corresponding to an application of the PaaS system, and sending, by the control server, the identification of the candidate container to a PaaS master component of the PaaS system and a request to migrate the candidate container from the distressed node.

Abstract: A method of evaluating pilot performance receives and processes avionics data at a database system. The database system computes component scores for the pilot based on the avionics data. Each component score represents a performance grade for a pilot-controlled operation of the aircraft. The database system saves the component scores in association with a pilot performance record for the pilot, and calculates an overall score based on the component scores. The overall score represents a flight performance grade for the pilot. The database system saves the overall score in association with the pilot performance record, and generates a report derived from the component scores and the overall score. A graphical representation of the report is communicated to an electronic device.

Abstract: Implementations provide for automated container migration in a Platform-as-a-Service (PaaS) system. A method of the disclosure includes receiving, by a processing device executing a control server of a multi-tenant Platform-as-a-Service (PaaS) system, identification of a distressed node of the multi-tenant PaaS system and a resource under contention at the distressed node, providing, by the control server, identification of the resource under contention to the distressed node, receiving, by the control server, identification of a candidate container executing on the distressed node, wherein the candidate container contributes to the resource under contention on the distressed node and is launched from an instance of an application image corresponding to an application of the PaaS system, and sending, by the control server, the identification of the candidate container to a PaaS master component of the PaaS system and a request to migrate the candidate container from the distressed node.

Abstract: The present invention generally relates to a nicotinamide adenine dinucleotide (NAD) biosynthesis system and methods of screening for NAD biosynthesis effectors. Among the various aspects of the present invention is the provision of an in vitro-reconstituted mammalian NAD biosynthesis system that can be used for the high-throughput screening of chemical activators and inhibitors for mammalian NAD biosynthesis. Another aspect of the invention provides a method of identifying a compound that effects in vivo activity of NAD metabolic enzymes. Further aspects of the invention include nucleic acid sequences, vectors, and transformed cells that can be used in the methods described herein.

Abstract: The present invention generally relates to a nicotinamide adenine dinucleotide (NAD) biosynthesis system and methods of screening for NAD biosynthesis effectors. Among the various aspects of the present invention is the provision of an in vitro-reconstituted mammalian NAD biosynthesis system that can be used for the high-throughput screening of chemical activators and inhibitors for mammalian NAD biosynthesis. Another aspect of the invention provides a method of identifying a compound that effects in vivo activity of NAD metabolic enzymes. Further aspects of the invention include nucleic acid sequences, vectors, and transformed cells that can be used in the methods described herein.